Search clinical trials for: anti CD20
Total 160248 results
-
Tianjin Medical University Cancer Institute and...Nanjing Legend Biotech Co.RecruitingB-Cell Non-Hodgkin Lymphoma-Recurrent | B-Cell Non-Hodgkin Lymphoma-RefractoryChina
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Legend Biotech Co.RecruitingRelapsed and Refractory B-cell Non-Hodgkin LymphomaChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingConnective Tissue Diseases | Autoantibodies | Immune Thrombocytopenia (ITP) | Evan SyndromeChina
-
Istituto Giannina GasliniBambino Gesù Hospital and Research InstituteTerminatedNephrotic Syndrome Steroid-DependentItaly
-
Hoffmann-La RocheCompleted
-
National University Hospital, SingaporeNational University of SingaporeUnknownPilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell MalignanciesNon-Hodgkin's Lymphoma | B-Cell Chronic Lymphocytic LeukemiaSingapore
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedDLBCLBulgaria, Estonia, France, Hungary, Italy, Latvia, Poland, Russian Federation, Spain, Ukraine
-
Centre Hospitalier Universitaire de BesanconTerminatedHematological Malignancies BFrance
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.RecruitingStudy of IMM0306 in Patients With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin's LymphomaCD20-positive B-cell Non-Hodgkin's LymphomaChina
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicUnited States, United Kingdom
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Haukeland University HospitalTerminatedChronic Fatigue Syndrome | Myalgic EncephalomyelitisNorway
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Small Lymphocytic Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory... and other conditionsUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedLymphomaUnited States
-
The Lymphoma Academic Research OrganisationRoche Pharma AGRecruitingFollicular LymphomaFrance
-
University Medical Center GroningenHoffmann-La RocheCompleted
-
Prof. Dr. Clemens SchmittCharite University, Berlin, Germany; Janssen-Cilag Ltd.Active, not recruitingDiffuse Large B Cell LymphomaGermany
-
Shanghai Institute Of Biological ProductsCompletedDiffuse Large B-Cell LymphomaChina
-
Joseph TuscanoNational Cancer Institute (NCI); CelgeneActive, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Chronic Lymphocytic Leukemia | Refractory Hairy Cell Leukemia | Refractory Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Shanghai Henlius BiotechCompleted
-
ImmunityBio, Inc.Withdrawn
-
H. Lee Moffitt Cancer Center and Research InstituteCelgene CorporationCompletedMantle Cell Lymphoma | Lymphocytic LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
Cancer Research UKBioInvent International AB; BloodwiseCompletedB-cell Lymphoma | Waldenström Macroglobulinemia | Chronic Lymphocytic LeukaemiaUnited Kingdom
-
Genzyme, a Sanofi CompanyTerminatedNon-Hodgkin's LymphomaUnited States
-
University Health Network, TorontoHoffmann-La Roche; Ozmosis Research Inc.CompletedLymphoma, Non-Hodgkin'sCanada
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedWaldenström MacroglobulinemiaUnited States
-
Medical University of ViennaTerminated
-
Chiron CorporationTerminatedNon-Hodgkin LymphomaUnited States
-
Jean M. Tersak, M.D.Genentech, Inc.TerminatedNeuroblastoma | Opsoclonus-myoclonus
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Beth ChristianGenentech, Inc.; CelgeneActive, not recruitingRecurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Burkitt Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma and other conditionsUnited States
-
CelgeneActive, not recruitingLymphomaUnited States, France, Germany, Italy, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States
-
Centre Henri BecquerelCompletedFollicular Lymphoma | Mantle Cell LymphomaFrance
-
Cancer Institute and Hospital, Chinese Academy...Enrolling by invitationDiffuse Large B Cell LymphomaChina
-
Istituto Giannina GasliniRecruiting
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | CD20-Positive Neoplastic Cells Present | Refractory Mature B-Cell Non-Hodgkin LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
The Lymphoma Academic Research OrganisationGrupo Español de Linfomas y Transplante Autólogo de Médula Ósea; Swiss Group... and other collaboratorsRecruitingFollicular LymphomaBelgium, France, Germany, Portugal, Spain
-
National Cancer Institute (NCI)RecruitingLymphoma, B-Cell | Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCureTech LtdCompleted
-
Yang TaoCompleted
-
National Institute of Diabetes and Digestive and...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedType 1 Diabetes MellitusUnited States, Canada, Italy, Australia
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Brazil, Poland, United Kingdom, Turkey, Bulgaria, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Mexico, Argentina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
Hoffmann-La RocheRecruitingLymphoma, Non-HodgkinUnited States, Belgium, Australia, Denmark, Italy, Spain, France, United Kingdom
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Sumithira VasuNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent High Grade... and other conditionsUnited States